Antihemophilic Factor (Recombinant), Formulated with Sucrose - Helixate FS; Factor VIII, recombinant -- Product Record

Factor VIII, rDNA BHK/CSL

    Nomenclature:
      Factor VIII, rDNA BHK/CSL [BIO]
      Helixate [TR prior to FS]
      Helixate FS [TR current FS formulation]
      Helixate NexGen [TR foreign in Europe]
      Antihemophilic Factor (Recombinant) [FDA prior to FS]
      Antihemophilic Factor (Recombinant), Formulated with
      Sucrose [FDA]
      octocog alfa [INN]
      Antihemophilic Factor [USAN]
      Antihemophilic Factor, Human [USAN former ]
      Factor VIII (rDNA) [BAN]
      Antihemophilic Factor USP [USP]
      Blood-coagulation factor VIII, complex [CAS]
      AHF [SY]
      Factor VIII, recombinant [SY]
      NDC 0053-8120-01; NDC 0053-8120-02; NDC 0053-8120-04 [NDC]

    FDA Class:  Biologic PLA BLA

    Year of approval (FDA) = 1993